Niagen Bioscience, Inc. — Director's Dealing 2010

May 24, 2010

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2010-05-20

Reporting Person: Brauser Michael (Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2142856	Direct
Common Stock	1503570	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant to Purchase Common Stock	$0.21	2013-05-20	Common Stock (2142856)		Direct
Warrant to Purchase Common Stock	$0.21	2013-05-20	Common Stock (1503570)		Indirect

Footnotes

F1: Ownership: Michael & Betsy Brauser TBE purchased 1,785,714 shares of common stock and was issued an immediately exercisable warrant to acquire 1,785,714 additional shares at $0.21 per share; Betsy Brauser Third Amended Trust Agreement ( beneficially owned by the spouse and disclaimed by the Reporting Person) purchased 357,142 shares of common stock and was issued an immediately exercisable warrant to acquire 357,142 additional shares of common stock at $0.21 per share

F2: Ownership: Grander Holdings, Inc 401K profit Sharing Plan( Of which, the Reporting Person is Trustee) purchased 314,285 shares of commons stock and was issued an immediately exercisable warrant to acquire 314,285 additional shares at $0.21 per share. Brauser 2010 GRAT( of which, the Reporting Person is trustee) purchased 342,857 shares of common stock and was issued an immediately exercisable warrant to acquire 342,857 additional shares at $0.21 per share. BMB Holdings, LLLP (of which, the Reporting Person is the Manager of its General Partner) purchased 846,428 shares of common stock and was issued an immediately exercisable warrant to acquire 846,428 additional shares at $0.21 per share.